Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Acute and long-term effectiveness of clozapine in treatment-resistant psychotic depression
Rakesh Ranjan, Herbert Y. Meltzer
Biological Psychiatry (1996) Vol. 40, Iss. 4, pp. 253-258
Closed Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

Serotonin receptors : their key role in drugs to treat schizophrenia
Herbert Y. Meltzer, Zhu Li, Y Kaneda, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2003) Vol. 27, Iss. 7, pp. 1159-1172
Closed Access | Times Cited: 765
Treatment-Resistant Schizophrenia - The Role of Clozapine
Herbert Y. Meltzer
Current Medical Research and Opinion (1997) Vol. 14, Iss. 1, pp. 1-20
Closed Access | Times Cited: 468
Depression in Schizophrenia: Perspective in the Era of “Atypical” Antipsychotic Agents
Samuel G. Siris
American Journal of Psychiatry (2000) Vol. 157, Iss. 9, pp. 1379-1389
Closed Access | Times Cited: 422
Suicide and schizophrenia
Samuel G. Siris
Journal of Psychopharmacology (2001) Vol. 15, Iss. 2, pp. 127-135
Closed Access | Times Cited: 402
Comorbid anxiety and depression.
Mark H. Pollack
PubMed (2005) Vol. 66 Suppl 8, pp. 22-9
Closed Access | Times Cited: 209
Pharmacological treatment of negative symptoms of schizophrenia: therapeutic opportunity or Cul‐de‐sac?
P.F. Buckley, Stephen M. Stahl
Acta Psychiatrica Scandinavica (2007) Vol. 115, Iss. 2, pp. 93-100
Open Access | Times Cited: 162
Clozapine for treatment-resistant bipolar disorder: a systematic review
Xianbin Li, Yi‐lang Tang, Chuanyue Wang, et al.
Bipolar Disorders (2014) Vol. 17, Iss. 3, pp. 235-247
Open Access | Times Cited: 135
Association of the MscI Polymorphism of the Dopamine D3 Receptor Gene with Tardive Dyskinesia in Schizophrenia
Vincenzo S. Basile, Mario Masellis, Farideh Badri, et al.
Neuropsychopharmacology (1999) Vol. 21, Iss. 1, pp. 17-27
Open Access | Times Cited: 163
Olanzapine and Clozapine Increase the GABAergic Neuroactive Steroid Allopregnanolone in Rodents
Brian P. Marx, Margaret J. VanDoren, Gary E. Duncan, et al.
Neuropsychopharmacology (2003) Vol. 28, Iss. 1, pp. 1-13
Open Access | Times Cited: 142
Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome
Sang Chul Jeon, Yong‐Ku Kim
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 10, pp. 2174-2174
Open Access | Times Cited: 76
Clozapine in the Treatment of Refractory Psychotic Mania
A. I. Green, Maricio Tohen, Jayendra K. Patel, et al.
American Journal of Psychiatry (2000) Vol. 157, Iss. 6, pp. 982-986
Closed Access | Times Cited: 134
Comparative efficacy of olanzapine and haloperidol for patients with treatment-resistant schizophrenia∗∗See accompanying Editorial, in this issue.
Alan Breier, S.H. Hamilton
Biological Psychiatry (1999) Vol. 45, Iss. 4, pp. 403-411
Closed Access | Times Cited: 127
Treatment-resistant schizophrenic patients respond to clozapine after olanzapine non-response
Robert R. Conley, C.A. Tamminga, Deanna L. Kelly, et al.
Biological Psychiatry (1999) Vol. 46, Iss. 1, pp. 73-77
Closed Access | Times Cited: 123
Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics
Mark A. Frye
Journal of Affective Disorders (1998) Vol. 48, Iss. 2-3, pp. 91-104
Closed Access | Times Cited: 110
Challenges in the treatment of depression with psychotic features
Anthony J. Rothschild
Biological Psychiatry (2003) Vol. 53, Iss. 8, pp. 680-690
Closed Access | Times Cited: 101
Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens
Junji Ichikawa, Toshihide Kuroki, Jin Dai, et al.
European Journal of Pharmacology (1998) Vol. 351, Iss. 2, pp. 163-171
Closed Access | Times Cited: 86
Antisuicide Properties of Psychotropic Drugs: A Critical Review
Carrie L. Ernst, Joseph F. Goldberg
Harvard Review of Psychiatry (2004) Vol. 12, Iss. 1, pp. 14-41
Closed Access | Times Cited: 84
Antipsychotic and antidepressive effects of second generation antipsychotics
Hans‐Jürgen Möller
European Archives of Psychiatry and Clinical Neuroscience (2005) Vol. 255, Iss. 3, pp. 190-201
Closed Access | Times Cited: 83
Metabolic changes associated with antipsychotic use.
Joseph A. Lieberman
PubMed (2004) Vol. 6, Iss. Suppl 2, pp. 8-13
Closed Access | Times Cited: 79
Clozapine prescription pattern in patients with schizophrenia in Asia: The REAP survey (2016)
Shi-Wei Xu, Min Dong, Qinge Zhang, et al.
Psychiatry Research (2019) Vol. 287, pp. 112271-112271
Closed Access | Times Cited: 40
Antidepressive effects of traditional and second generation antipsychotics: a review of the clinical data
Hans‐Jürgen Möller
European Archives of Psychiatry and Clinical Neuroscience (2005) Vol. 255, Iss. 2, pp. 83-93
Closed Access | Times Cited: 60
Suicide attempts in veterans with bipolar disorder during treatment with lithium, divalproex, and atypical antipsychotics
Eileen P. Ahearn, Peijun Chen, Michael A. Hertzberg, et al.
Journal of Affective Disorders (2012) Vol. 145, Iss. 1, pp. 77-82
Open Access | Times Cited: 42
Somatic Treatment of Psychotic Depression: Review and Recommendations for Practice
Jason A. Wheeler Vega, Ann Mortimer, Philip John Tyson
Journal of Clinical Psychopharmacology (2000) Vol. 20, Iss. 5, pp. 504-519
Closed Access | Times Cited: 67
Electroconvulsive Therapy in Movement Disorders: An Update
Richard Kennedy, Dinesh Mittal, Judith O’Jile
Journal of Neuropsychiatry (2003) Vol. 15, Iss. 4, pp. 407-421
Closed Access | Times Cited: 60
The Psychopharmacology Algorithm Project at the Harvard South Shore Program: An Update on Psychotic Depression
Hesham M. Hamoda, David N. Osser
Harvard Review of Psychiatry (2008) Vol. 16, Iss. 4, pp. 235-247
Open Access | Times Cited: 48
Page 1 - Next Page

Scroll to top